BAY 2731954
E1555609
UNEXPLORED
BAY 2731954 is a highly selective small-molecule inhibitor of TRK kinases developed as a targeted therapy for cancers driven by NTRK gene fusions.
All labels observed (1)
| Label | Occurrences |
|---|---|
| BAY 2731954 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22796800 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: BAY 2731954 Context triple: [LOXO-195, hasAlternativeName, BAY 2731954]
-
A.
TAK-079
TAK-079 is an investigational human monoclonal antibody designed to deplete CD38-expressing cells, primarily being developed for the treatment of multiple myeloma and certain autoimmune diseases.
-
B.
Talycopa
Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
-
C.
GS-5734
GS-5734, better known by its generic name remdesivir, is a broad-spectrum antiviral medication used to treat infections such as COVID-19.
-
D.
Tasigna
Tasigna is a prescription tyrosine kinase inhibitor used primarily to treat certain types of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in adults and children.
-
E.
Vilapicina
Vilapicina is a Barcelona Metro station in the Horta-Guinardó district that serves as part of the city's Line 5 network.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: BAY 2731954 Target entity description: BAY 2731954 is a highly selective small-molecule inhibitor of TRK kinases developed as a targeted therapy for cancers driven by NTRK gene fusions.
-
A.
TAK-079
TAK-079 is an investigational human monoclonal antibody designed to deplete CD38-expressing cells, primarily being developed for the treatment of multiple myeloma and certain autoimmune diseases.
-
B.
Talycopa
Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
-
C.
GS-5734
GS-5734, better known by its generic name remdesivir, is a broad-spectrum antiviral medication used to treat infections such as COVID-19.
-
D.
Tasigna
Tasigna is a prescription tyrosine kinase inhibitor used primarily to treat certain types of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in adults and children.
-
E.
Vilapicina
Vilapicina is a Barcelona Metro station in the Horta-Guinardó district that serves as part of the city's Line 5 network.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.